The Next Chapter of DDR Inhibitor Development Across Cancers
Time: 8:30 am
day: Day One
Details:
• Reflecting on lessons learned from updates in DDR inhibitor development in the past 12 months
• Combination therapies: overcoming toxicity challenges and PARP inhibitor resistance
• Highlighting future directions for DDR inhibitors
